Sixty-five years since the New York heat wave: Advances in sweat testing for cystic fibrosis

Pediatric Pulmonology

Volumn 49, Issue 2, 2014, Pages 106-117

  Collie, Jake T B ^a,b,c   Massie, R John ^c,d,e,f   Jones, Oliver A H ^a   Legrys, Vicky A ^g   Greaves, Ronda F ^a,c,f  

^a RMIT UNIVERSITY   (Australia)

^b Dorevitch Pathology   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Sweat Test Working Party   (Australia)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

best practice guidelines; CFTR activation; cystic fibrosis; standardization; sweat chloride methods; sweat test

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROLYTE; PILOCARPINE; SODIUM CHANNEL;

ANALYTIC METHOD; CYSTIC FIBROSIS; DEHYDRATION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE TRANSPORT; FEVER; GENETICS; GOLD STANDARD; GROUPS BY AGE; HUMAN; IONTOPHORESIS; MASS SPECTROMETRY; PATHOPHYSIOLOGY; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SHOCK; STANDARDIZATION; SWEAT; SWEAT GLAND FUNCTION;

BEST PRACTICE GUIDELINES; CFTR ACTIVATION; CYSTIC FIBROSIS; STANDARDIZATION; SWEAT CHLORIDE METHODS; SWEAT TEST;

BIOLOGICAL MARKERS; CHLORIDES; CLINICAL CHEMISTRY TESTS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HOT TEMPERATURE; HUMANS; NEW YORK; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; SPECIMEN HANDLING; SWEAT;

EID: 84892924141     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22945     Document Type: Review

References (81)

1. Andersen HD,. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 1938; 56: 344-399.
2. Quinton PM,. Cystic fibrosis: lessons from the sweat gland. Physiology 2007; 22: 212-225.
3. Kessler WR, Andersen HD,. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 1951; 8: 648-656.
4. Di Sant' Agnese PA, Darling RC, Perera GA, Shae E,. Abnormal electrolyte compostition of sweat in cystic fibrosis of the pancreas: clinical significance and relationship to the disease. Pediatrics 1953; 12: 549-563.
5. Mauer AM, West CD,. A simple method for collection and analysis of sweat for chloride. Am J Dis Child 1956; 92: 160-163.
6. Misch KA, Holden HM,. Sweat test for the diagnosis of fibocystic disease of the pancreas. Report of a fatality. Arch Dis Child 1958; 33: 179-180.
7. Shwachman H, Gahm N,. Studies in cystic fibrosis. Simple test for detection of excessive chloride on the skin. N Engl J Med 1956; 255: 999-1001.
8. Webb BW, Flute PT, Smith MJH,. The electrolyte content of the sweat in fibrocystic disease of the pancreas. Arch Dis Child 1957; 32: 82-84.
9. Gluck L,. A patch test for chloride in sweat as a simple screening method for detecting cystic fibrosis of the pancreas: preliminary report. Pediatrics 1959; 23: 731-737.
10. Gibson LE, Cooke RE,. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23: 5.
11. Scott MG, LeGrys VA, Klutts JS,. Electrolytes and blood gases. In:, Burtis CA, Ashwood ER, Bruns DE, editors. Tietz: fundamentals of clinical chemistry, 6th edition. Missouri: Saunders; 2008. pp 431-449.
12. Davies LD, Wilson TE, Vener JM, Crandall CG, Petajan JH, White AT,. Pilocarpine-induced sweat gland function in individuals with multiple sclerosis. J Appl Physiol 2005; 98: 1740-1744.
13. Schwarz V, Sutcliffe CH, Style PP,. Some hazards of the sweat test. Arch Dis Child 1968; 43: 695-701.
14. Davis PB, Di Sant' Agnese PA,. Diagnosis and treatment of cystic fibrosis: an update. Chest 1984; 85: 802-809.
15. David TJ,. Cystic fibrosis. Arch Dis Child 1990; 65: 152-157.
16. Naehrlich L, Bagheri-Behrouzi A,. German CF quality assurance group. Misdiagnosis of cystic fibrosis-experience from Germany. J Cyst Fibros 2013; 12: 68-73.
17. Webster HL,. Laboratory diagnosis of cystic fibrosis. Crit Rev Cl Lab Sci 1983; 23: 545-549.
18. Wescor Inc. http://www.wescor.com/biomedical/cysticfibrosis/macroduct. html
19. Hammond KB, Turcios NL, Giboson LE,. Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 1994; 124: 255-260.
20. The AACB Sweat Test Working Party. Australian Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis. Clin Biochem Rev 2006; 27: S1-S7.
21. Multi Disciplinary Working Group. Guidelines for the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK, 1st edition. Multi Disciplinary Working Group: 2003.
22. Mastella G, Di Cesare G, Borruso A, Menin L, Zanolla L,. Reliability of sweat-testing by the macroduct collection method combined with conductivity analysis in comparison with the classic gibson and cook technique. Acta Paediatr 2000; 89: 933-937.
23. CLSI. Sweat testing: sample collection and quantitative analysis: approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
24. Mishra A, Greaves R, Massie J, Smith K, Wootton A, Sterling R, Carlin J,. The diagnosis of cystic fibrosis by sweat test: age specific reference intervals. J Pediatr 2008; 153: 758-763.
25. Jayaraj R, Barton PV, Newland P, Mountford R, Shaw NJ, McCarthy E, Isherwood DM, Southern KW,. A reference interval for sweat chloride in infants aged between five and six weeks of age. Ann Clin Biochem 2009; 46: 73-78.
26. Kirk JM,. A continuing role for sweat testing in and era of newborn screening for cystic fibrosis. Clin Biochem 2011; 44: 487-488.
27. Knowles MR, Gatzy JT, Boucher RC,. Increased bio-electric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981; 305: 1489-1495.
28. Kopelman H, Corey M, Gaskin K, Durie PR, Weizman Z, Forstner G,. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 1988; 95: 349-355.
29. - secretion in cystic fibrosis. Pediat Res 1982; 16: 554-557.
30. Quinton PM,. Chloride impermeability in cystic fibrosis. Nature 1983; 301: 421-422.
31. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C,. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
32. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary. DNA Sci 1989; 245: 1066-1073.
33. Rommens JM, Lannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Collins FS, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
34. Cystic Fibrosis Mutation Database. http://www.genet.sickkids.on.ca/app
35. Mishra A, Greaves R, Massie J,. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005; 26: 135-153.
36. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, LeGrys VA, Massie J, Parad RB, Rock MJ, Campbell PW,. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008; 153: S4-S14.
37. Massie J, Clements B, Australian Paediatric Respiratory Group. Diagnosis of Cystic Fibrosis After Newborn Screening: The Australasian Experience-Twenty Years and Five Million Babies Later: A Consensus Statement From the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005; 39: 440-446.
38. Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz MD, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordonez CL, Campbell PW, Ashlock MA, Ramsey BW,. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010; 363: 1991-2003.
39. Ramsey BW, Davies J, McElvaney G, Tullis E, Bell SC, Drevinek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordonez CL, Elborn JS,. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365: 1663-1672.
40. Berwouts S, Morris MA, Girodon E, Schwarz M, Stuhrmann M, Dequeker E,. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme. Hum Mutat 2011; 32: 1197-1203.
41. Durmowicz AG, Witzmann KA, Rosebraugh CJ, Chowdhury BA,. Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: The Ivacaftor experience. Chest 2013; 143: 14-18.
42. Kirk JM,. Inconsistencies in sweat testing in UK Laboratories. Arch Dis Child 2000; 82: 425-427.
43. Mackay R, George P, Kirk JM,. Sweat testing for cystic fibrosis: a review of New Zealand laboratories. J Pediatr Child Health 2006; 42: 160-164.
44. Cirilli N, Padoan R, Raia V,. Audit of sweat testing: a first report from Italian Cystic Fibrosis Centres. J Cyst Fibros 2008; 7: 415-422.
45. NCCLS. Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline. East Lancaster Avenue, Villanova, Pennsylvania 19085: NCCLS; 1994.
46. Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D,. Recommandations Françaises pour la Réalisation et l'Interprétation du Test de la Sueur dans le Cadre du Dépistage Néonatal de la Mucoviscidose. Arch Fr Pediatr 2010; 17: 1349-1358.
47. Greaves RF,. A guide to harmonisation and standardisation of measurands determined by liquid chromatography-mass spectormetry in routine clinical biochemistry. Clin Biochem Rev 2012; 33: 123-132.
48. NCCLS. Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline, 2nd edition. West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA: NCCLS; 2000.
49. LeGrys VA, Yankaskas JR, Quittell LM, Marshall BC, Mogayzel PJ, Jr., Diagnostic sweat testing: The Cystic Fibrosis Foundation Guidelines. J Pediatr 2007; 151: 85-89.
50. Coakley J, Scott S, Mackay R, Greaves R, Jolly L, Massie J, Mishra A, Bransden A, Doery JCG, Chiriano A, Robins H,. Sweat testing for cystic fibrosis: standards of performance in Australasia. Ann Clin Biochem 2009; 46: 332-337.
51. Massie J,. Sweat testing for cystic fibrosis: how good is your laboratory ? J Pediatr Child Health 2006; 42: 153-154.
52. Augarten A, Hacham S, Kerem E, Kerem B, Szeinberg R, Laufer J, Doolman R, Altshuler R, Blau H, Bentur L, Gazit E, Katznelson D, Yahav Y,. The significance of Sweat Cl/Na ratio in patinets with boarderline sweat test. Pediatr Pulmonol 1995; 20: 369-371.
53. Massie J, Gaskin K, Van Asperen P, Wilcken B,. Sweat testing following newborn screening fo cystic fibrosis. Pediatr Pulmonol 2000; 29: 452-456.
54. Mishra A, Greaves R, Massie J,. The limitation of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systemic review. Clin Biochem Rev 2007; 28: 60-76.
55. Koerbin G, Greaves R, Robins H, Farquhar J, Hickman PE,. Total intra-individual variation in sweat sodium and chloride concentrations for the diagnosis of cystic fibrosis. Clin Chem Acta 2008; 393: 128-129.
56. Chiriano A, Greaves RF, Massie J, Scott S, Robins H, Angeles E, Doery JCG, Mishra A, Metz M, Joseph J, Mackay R, (AACB Sweat Testing Working Party). Sweat Electrolytes Program Circular. RCPA Quality Assurance Programs Pty Limited: RCPA Quality Assurance Programs; 2012. Available at: www.rcpaqap.com.au/chempath (Accessed 10th Nov 2013).
57. RCPA Quality Assurance Programs. Sweat Electrolyte End of Cycle 27 Report. www.rcpaqap.com.au/chempath (accessed 10th November 2013).
58. Mullen K,. Study on Stability of Sweat Stored in Microbore Tubing and in PCR 0.2ml Tubes Wescor, Logan Utah, 2008.
59. Australasian Association of Clinical Biochemists Sweat Testing Working Party Minutes. 26 October 2010. Adelaide. http://www.aacb.asn.au/ professionaldevelopment/sweat-testing (Accessed 10th November 2013)
60. Australasian Association of Clinical Biochemists Sweat Testing Working Party Minutes. 25 May 2011. Adelaide. http://www.aacb.asn.au/ professionaldevelopment/sweat-testing (Accessed 10th November 2013)
61. Warwick WJ, Hansen L,. Measurement of chloride in sweat with the chloride-selective electrode. Clin Chem 1978; 24: 2050-2053.
62. Schwachman H, Mahmoodian A, Neff RK,. The sweat test: sodium and chloride values. J Pediatr 1981; 98: 576-578.
63. Kirk JM, Keston M, McIntosh I, al Essa S,. Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases. Ann Clin Biochem 1992; 29: 145-152.
64. Farrell PM, Koscik RE,. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 1996; 97: 524-528.
65. Massie J, Gillam L,. Uncertain diagnosis after newborn screening for cystic fibrosis: an ethics based approach to a clinical dilemma. Pediatr Pulmonol 2013 (in press).
66. Mackay RJ, Florkowski CM, George PM, Sies CW, Woods S,. Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing ? Ann Clin Biochem 2008; 45: 535-538.
67. Barben J, Ammann RA, Metlagel A, Schoeni MH,. Swiss Paediatric Respiratory Research G. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 2005; 146: 183-188.
68. Licht TS, Stern M, Schwachman H,. Measurement of electrical conductivity of sweat: its application to the study of cystic fibrosis of the pancreas. Clin Chem 1957; 3: 37-48.
69. Desax M, Ammann AA, Hammer J, Schoeni MH, Barben J,. Nanoduct sweat testing for rapid diagnosis in newborns. infants and children with cystic fibrosis. Eur J Pediatr 2008; 167: 299-304.
70. Funk MJ, LeGrys VA,. Testing diagnostic tests: why size matters. J Pediatr 2005; 146: 159-162.
71. Losty HC, Wheatley H, Doull I,. The evaluation of novel conductometric device for the diagnosis of cystic fibrosis. Ann Clin Biochem 2006; 43: 375-381.
72. Farahmand F, Sadjadel N, Haghi-Ashtiani M, Modaresi V, Rezael N, Pakseresht B,. Comparison of classic sweat test and crystalization test in diagnosis of cystic fibrosis. Iran J Pediatr 2011; 22: 102-106.
73. Bureau International des Poids et Mesures. JCTLM: Joint Committee for Traceability in Laboratory Medicine Database: Laboratory Medicine and In Vitro Diagnostics. 2013.
74. Annesley TM, Rockwood AL, Sherman NE,. Mass spectrometry. In:, Burtis CA, Ashwood ER, Bruns DE, editors. Tietz: fundamentals of clinical chemistry, 6th edition. Missouri: Saunders Elsevier; 2008. pp 128-139.
75. Murayama C, Kimura Y, Setou M,. Imaging mass spectrometry: pinciple and application. Biophys Rev 2009; 1: 131-139.
76. Boulyga SF, Heilmann J, Prohaska T, Heumann KG,. Development of an accurate, sensitive, and robust isotope dilution laser ablation icp-ms method for simultaneous multi-element analysis (chlorine, sulfur, and heavy metals) in coal samples. Anal Bioannal Chem 2007; 389: 697-706.
77. Vanhoe H,. A Review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J Trace Elem 1993; 7: 131-140.
78. Chan S, Gerson B, Reitz RE, Sadjadi SA,. Technical and clinical aspects of spectrometric analysis of trace elements in clinical samples. Clin Lab Med 1998; 18: 615-629.
79. Cystic Fibrosis Foundation Patient Registry. 2010 Annual Data Report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2010
80. Quinton PM, Molyneux L, Ip W, Dupuis A, Avolio J, Tullis E, Conrad D, Shamsuddin AK, Durie PR, Gonska T,. β-Adrenergic sweat secretion as a diagnostic test for cystic fibrosis. Am J Respir Crit Care Med 2012; 186: 732-739.
81. Elkeeb R, Hui X, Chan H, Tian L, Maibach HI,. Correlation of transepidermal water loss with skin barrier properties in vitro: comparison of three evaporimeters. Skin Res Technol 2010; 16: 9-15.